Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

BCAT1 anticorps

BCAT1 Reactivité: Humain, Souris, Chien WB, IHC Hôte: Souris Monoclonal 3F5 unconjugated
N° du produit ABIN2716546
  • Antigène Voir toutes BCAT1 Anticorps
    BCAT1 (Branched Chain Amino-Acid Transaminase 1, Cytosolic (BCAT1))
    Reactivité
    • 45
    • 24
    • 20
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    Humain, Souris, Chien
    Hôte
    • 61
    • 6
    Souris
    Clonalité
    • 63
    • 4
    Monoclonal
    Conjugué
    • 30
    • 5
    • 5
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp BCAT1 est non-conjugé
    Application
    • 50
    • 29
    • 23
    • 14
    • 13
    • 13
    • 9
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC)
    Attributs du produit
    Homo sapiens branched chain amino-acid transaminase 1, cytosolic (BCAT1), transcript variant 1
    Purification
    Purified from mouse ascites fluids by affinity chromatography
    Immunogène
    Full length human recombinant protein of human BCAT1(NP_005495) produced in HEK293T cell.
    Clone
    3F5
    Isotype
    IgG2a
    Top Product
    Discover our top product BCAT1 Anticorps primaire
  • Indications d'application
    WB 1:500~2000, IHC 1:150,
    Commentaires

    The concentration of the product may vary between diferrent lots.

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.5-1.0 mg/mL
    Buffer
    PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
  • Cho, Jeon, Park, Park, Kang, Choi: "BCAT1 is a New MR Imaging-related Biomarker for Prognosis Prediction in IDH1-wildtype Glioblastoma Patients." dans: Scientific reports, Vol. 7, Issue 1, pp. 17740, (2017) (PubMed).

    Hattori, Tsunoda, Konuma, Kobayashi, Nagy, Glushka, Tayyari, McSkimming, Kannan, Tojo, Edison, Ito: "Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia." dans: Nature, Vol. 545, Issue 7655, pp. 500-504, (2017) (PubMed).

  • Antigène
    BCAT1 (Branched Chain Amino-Acid Transaminase 1, Cytosolic (BCAT1))
    Autre désignation
    BCAT1 (BCAT1 Produits)
    Synonymes
    anticorps fj66g02, anticorps zgc:73157, anticorps wu:fj66g02, anticorps Bcatc, anticorps BCATC, anticorps BCT1, anticorps ECA39, anticorps MECA39, anticorps PNAS121, anticorps PP18, anticorps BCATc, anticorps Eca39, anticorps branched chain amino-acid transaminase 1, cytosolic, anticorps branched chain amino acid transaminase 1, anticorps branched chain amino-acid transaminase 1, cytosolic L homeolog, anticorps branched chain aminotransferase 1, cytosolic, anticorps bcat1, anticorps BCAT1, anticorps bcat1.L, anticorps Bcat1
    Sujet
    This gene encodes the cytosolic form of the enzyme branched-chain amino acid transaminase. This enzyme catalyzes the reversible transamination of branched-chain alpha-keto acids to branched-chain L-amino acids essential for cell growth. Two different clinical disorders have been attributed to a defect of branched-chain amino acid transamination: hypervalinemia and hyperleucine-isoleucinemia. As there is also a gene encoding a mitochondrial form of this enzyme, mutations in either gene may contribute to these disorders. Alternatively spliced transcript variants have been described.
    Poids moléculaire
    42.8 kDa
    ID gène
    586
    NCBI Accession
    NM_005504
    HGNC
    586
Vous êtes ici:
Support technique